Member Info for Celtic007

Yep if data especially safety profile good for 1801 then safety wise 1802 be fine....

Nope ....not linked to sareum.

Our CHK1 will get licensed, 100 percent....data on combo too good to be ignored .

Agree ben. I always been very excited about 1801 but know of other clever people more excited by 1802

Good wording sareum .... This data will be very good. As sadoldgit said, we will easily match or beat the best drug in posrisis. He knows better than most, the science behind these .

Schkler been here long time and a good contributor

Roberto knows better than these billionaires....very clever boy. A tucking twix

Roberto the tool....you are here like a irritating yeast infection,talking nonsense. This is not going to go cheap. Get a life FFS

I second Lazarus ...great research hbd .. appreciated by all genuine investors here.

BRING ON THE DATA BABY

Funny guy , take a break FFS ...you talk utter tosh.

All the best boysuka. No problems with you trading and well done but am happy to wait. More chance of these results being good, than bad. Am very sure of that.

Hi potnak. Thanks for reply. The fact original team back, speaks volumes. Hope it goes for a fair value and we get a good amount for all that hard work.

Matter of time hopefully

Hi potnak. Surely we all judge our CHK1 on the data shown and that has been. Amazing....surely you agree? Siera will ecstatic about it before they got involved with mono...

I go by the data shown and the untreatable cancers it has shown great data in ...and also the scientists and Dr involved with it.

Surely you agree with above? The problem could be that combo or triple therapy needed but it works and it works great and umet needs

You really have a cheeky talking about conspiracy theories, you fool FG. when you posted your tripe, I bet you thought it was financial journalism of the highest standard. Tool

Apologies boysuka, if you are a holder. Nothing is guaranteed but I be stunned if our data is not great and basically we will be screwed

These lot on charge don't know much about business but science, they know fantastically well.

We should kick ass in posrisis and the fact we can increase dosage 30 times the allowed dose and no side effects is amazing

Am sure sadoldgit has commented on posrisis link and why.we going after this indication

This molecule kicked the leading psoriasis drug in laboratory trials, as thoth caught.on, all them years ago.

It's coming along.nicely.

Boysuka....another turnip that turns up.

More shares in circulation...yes but if molecule good and going by the market rate them high values possible, albeit lower than could have been.

Simply, if data good then multiples of today . Tell me what share price be if 500 million cap....cheap

Agree ?

Sareum were quick to realise mhra were useless and changed tactics ...done a 360 degree turn literally...credit to them, as we bash them when we are angry.

Fannyguy is back, the mystic keg of the financial market. You talk so much nonsense.

Your last post 30th April

Down to 10p me thinks

Plonker is what you are ...

Exactly ...Lazarus. great research and so nice to have all the septic people nearly out of here. See funny guy still here, like a bad fart, but the data released soon going to act like a deodorant to neutralise him and his shorting bricks

Great research thank you. Am sure this company makes a asthma drug called spiriva as well . Thank you . Big German pharmaceutical....a beast you would say